Clinical Trial Update: Depression in Alzheimer's Disease-2 [Phase 2, Phase 3]

View source ↗

Summary

The Depression in Alzheimer's Disease-2 trial, covering Phase 2 and Phase 3, has completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Major Depressive Disorder

Snippet

Sponsor: Johns Hopkins University | Conditions: Alzheimer's Disease, Depression | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-04-11